424 related articles for article (PubMed ID: 20224986)
41. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
Liu H; Song X; Hou J; Zhao Z; Chang J
DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
[TBL] [Abstract][Full Text] [Related]
42. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.
Hamada S; Satoh K; Hirota M; Kanno A; Umino J; Ito H; Masamune A; Kikuta K; Kume K; Shimosegawa T
J Cell Physiol; 2012 Feb; 227(2):729-38. PubMed ID: 21465479
[TBL] [Abstract][Full Text] [Related]
43. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
Shishido Y; Ueno S; Yamazaki R; Nagaoka M; Matsuzaki T
Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
[TBL] [Abstract][Full Text] [Related]
44. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
45. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
[TBL] [Abstract][Full Text] [Related]
46. ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines.
Tang Y; Hou J; Li G; Song Z; Li X; Yang C; Liu W; Hu Y; Xu Y
Oncol Rep; 2014 Nov; 32(5):2168-74. PubMed ID: 25200103
[TBL] [Abstract][Full Text] [Related]
47. Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.
Ma Y; Liang D; Liu J; Axcrona K; Kvalheim G; Giercksky KE; Nesland JM; Suo Z
Tumour Biol; 2012 Aug; 33(4):967-78. PubMed ID: 22252524
[TBL] [Abstract][Full Text] [Related]
48. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
Jia Q; Zhang X; Deng T; Gao J
Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
[TBL] [Abstract][Full Text] [Related]
49. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
[TBL] [Abstract][Full Text] [Related]
50. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
51. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
52. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
[TBL] [Abstract][Full Text] [Related]
53. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
[TBL] [Abstract][Full Text] [Related]
54. ABCG2: determining its relevance in clinical drug resistance.
Robey RW; Polgar O; Deeken J; To KW; Bates SE
Cancer Metastasis Rev; 2007 Mar; 26(1):39-57. PubMed ID: 17323127
[TBL] [Abstract][Full Text] [Related]
55. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
[TBL] [Abstract][Full Text] [Related]
56. Characterization of a stem cell population in lung cancer A549 cells.
Sung JM; Cho HJ; Yi H; Lee CH; Kim HS; Kim DK; Abd El-Aty AM; Kim JS; Landowski CP; Hediger MA; Shin HC
Biochem Biophys Res Commun; 2008 Jun; 371(1):163-7. PubMed ID: 18423378
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
[TBL] [Abstract][Full Text] [Related]
58. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.
Dou J; Jiang C; Wang J; Zhang X; Zhao F; Hu W; He X; Li X; Zou D; Gu N
Cell Biol Int; 2011 Mar; 35(3):227-34. PubMed ID: 21108606
[TBL] [Abstract][Full Text] [Related]
59. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
Ding XW; Wu JH; Jiang CP
Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
[TBL] [Abstract][Full Text] [Related]
60. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
